BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04428151-completion@plaintrial.com
DTSTAMP:20261029T024150Z
DTSTART;VALUE=DATE:20251030
SUMMARY:Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-34
 75) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants W
 ith Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progre
 ssed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/
 LEAP-009) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04428151
URL:https://plaintrial.com/trial/NCT04428151
END:VEVENT
END:VCALENDAR